¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"Atropine psychosis"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 2 ÆäÀÌÁö: 1
¿µ¹® atropine ÇÑ±Û ¾ÆÆ®·ÎÇÉ
¼³¸í   
  ½Å°æÀü´Þ¹°ÁúÀÇ ÇÑ °¡Áö·Î ±ÙÀ°À» Áö¹èÇϴ ½Å°æÀÇ ¸»´Ü¿¡¼­ ºÐºñµÇ¾î ±ÙÀ°ÀÇ ¼öÃàÀ» À¯µµÇϱ⵵ Çϸç, ºÎ±³°¨½Å°æÀÇ ¸»´Ü¿¡¼­ ºÐºñµÇ¾î ºÎ±³°¨½Å°æÀÇ Àü´ÞÀ» ´ã´çÇϱ⵵ Çϰí, ³úÀÇ ½Å°æ¼¼Æ÷¿¡¼­µµ ºÐºñµÇ¾î ¿©·¯°¡Áö ÀÛ¿ëÀ» Çϴ ¾Æ¼¼Æ¿Äݸ°À̶ó´Â ¹°ÁúÀÇ ¿ªÇÒÀ» Â÷´ÜÇϴ ¹°ÁúÀÌ´Ù.
¿µ¹® psychosis ÇÑ±Û Á¤½Åº´
¼³¸í   
  ±âÁúÀû ¿øÀΠȤÀº ½É¸®Àû ¿øÀο¡ ÀÇÇØ »ý±â´Â ÁÖ¿ä Á¤½Åº´À» ÃÑĪÇϴ ¸»·Î, ÀΰÝÀÇ ¿ÍÇØ¿Í Çö½Ç°úÀÇ ±«¸®°¨, ¸Á»ó, È¯°¢, Âø°¢ µîÀÇ Áõ»óÀ» Æ¯Â¡À¸·Î ÇÑ´Ù.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • atropine
    ¾ÆÆ®·ÎÇÉ
  • arteriosclerotic psychosis
    µ¿¸Æ°æÈ­Á¤½Åº´
  • acute delusional psychosis
    ±Þ¼º¸Á»óÁ¤½Åº´
  • affective psychosis
    Á¤µ¿Á¤½Åº´
  • collective psychosis
    Áý´ÜÁ¤½Åº´
  • combat psychosis
    ÀüÅõÁ¤½Åº´
  • cycloid psychosis
    ¼øÈ¯ÇüÁ¤½Åº´
  • drug psychosis
    ¾à¹°Á¤½Åº´
  • degenerative psychosis
    ÅðÇàÁ¤½Åº´
  • deprivation psychosis
    ¹ÚÅ»Á¤½Åº´
  • disintegrative psychosis
    ºØ±«Á¤½Åº´
  • exogenous psychosis
    ¿ÜÀÎÁ¤½Åº´
  • experimental psychosis
    ½ÇÇèÁ¤½Åº´
  • endogenous psychosis
    ³»ÀÎÁ¤½Åº´
  • functional psychosis
    ±â´ÉÁ¤½Åº´
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 2 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • atropine
    ¾ÆÆ®·ÎÇÉ
  • psychosis
    Á¤½Åº´
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • atropine
    ¾ÆÆ®·ÎÇÉ
  • acute delusional psychosis
    ±Þ¼º¸Á»óÁ¤½Åº´
  • affective psychosis
    Á¤µ¿Á¤½Åº´
  • arteriosclerotic psychosis
    µ¿¸Æ°æÈ­Á¤½Åº´
  • collective psychosis
    Áý´ÜÁ¤½Åº´
  • combat psychosis
    ÀüÅõÁ¤½Åº´
  • cycloid psychosis
    ¼øÈ¯ÇüÁ¤½Åº´
  • degenerative psychosis
    ÅðÇàÁ¤½Åº´
  • deprivation psychosis
    ¹ÚÅ»Á¤½Åº´
  • disintegrative psychosis
    ºØ±«Á¤½Åº´
  • drug psychosis
    ¾à¹°Á¤½Åº´
  • endogenous psychosis
    ³»ÀÎÁ¤½Åº´
  • exogenous psychosis
    ¿ÜÀÎÁ¤½Åº´
  • experimental psychosis
    ½ÇÇèÁ¤½Åº´
  • famine psychosis
    ±â¾ÆÁ¤½Åº´
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • functional psychosis See psychosis
    ±â´É¼º Á¤½Åº´(Áõ)(ѦÒöàõïñãêÜ»)
  • Korsakoff s psychosis
    ÄÚ¸£»çÄÚÇÁÁ¤½Åº´.
  • Korsakoffs psychosis
    ÄÚ¸£»çÄÚÇÁÁ¤½ÅÁõ.
  • acute delusional psychosis
    ±Þ¼º ¸Á»ó¼º Á¤½Åº´
  • affective psychosis
    Á¤µ¿(¼º) Á¤½Åº´(ï×ÔÑàõïñãêÜ»).
  • amphetamine psychosis
    ¾ÏÆäŸ¹Î Á¤½ÅÁõ(º´)
  • gestational psychosis
    Àӽżº Á¤½Åº´.
  • hysterical psychosis
    È÷½ºÅ׸®(¼º) Á¤½Åº´(Áõ)(¡­ïñãêÜ»ñø)
  • induced psychosis
    °¨ÀÀ¼º Á¤½Åº´.
  • post traumatic neurosis , psychosis
    ¿Ü»óÈĽŰæÁõ, Á¤½ÅÁõ.
  • postoperative psychosis
    (¼ö)¼úÈÄÁ¤½Åº´ (¡­ïñãêÜ»).
  • postpartum psychosis
    »ê¿å±âÁ¤½Åº´, »êÈÄ Á¤½Åº´.
  • posttraumatic psychosis
    ¿Ü»óÈÄÁ¤½Åº´(¡­ïñãêÜ»).
  • presenile psychosis
    Ãʷμº Á¤½Åº´(ôøÖÕàõïñãêÜ»), Ãʷμº Á¤½ÅÀÌ»ó(¡­ïñãêì¶ ßÒ).
  • prison psychosis
    °¨¿ÁÁ¤½Åº´, ±¸±ÝÁ¤½Åº´(ϬÐ×ïñãêÜ»).
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • exogenous psychosis See psychosis
    ¿ÜÀμºÁ¤½Åº´(èâì×àõïñãêÜ»)
  • experimental psychosis See psychosis
    ½ÇÇèÁ¤½ÅÁõ(º´)(ãùúÐïñãêñø)
  • functional psychosis See psychosis
    ±â´É¼º Á¤½Åº´(Áõ)(ѦÒöàõïñãêÜ»)
  • acute delusional psychosis
    ±Þ¼º ¸Á»ó¼º Á¤½Åº´
  • affective psychosis
    Á¤µ¿(¼º) Á¤½Åº´(ï×ÔÑàõïñãêÜ»).
  • alcoholic psychosis
    ¾ËÄÚ¿Ã(Áßµ¶)¼º Á¤½Åº´.
  • amphetamine psychosis
    ¾ÏÆäŸ¹Î Á¤½ÅÁõ(º´)
  • arteriosclerotic psychosis
    µ¿¸Æ°æÈ­¼º Á¤½ÅÁõ(º´)
  • arteriosclerotic psychosis
    µ¿¸Æ°æÈ­¼º Á¤½Åº´.
  • assaultive psychosis
    °ø°Ý¼º Á¤½ÅÁõ
  • associated psychosis
    ¼ö¹Ý(âËÚᣩÁ¤½Åº´
  • association psychosis
    ¿¬»óÁ¤½ÅÁõ
  • atypical psychosis
    ºñÁ¤Çü Á¤½Åº´
  • borderline psychosis
    °æ°è¼º Á¤½Åº´(ÌÑÍ£àõ ïñãêÜ»)
  • brief reactive psychosis
    ´Ü±â¹ÝÀÀ¼º Á¤½Åº´
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 1 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • atropine
    ¾ÆÆ®·ÎÇÉ
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 1 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • psychosis
    Á¤½Åº´
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 1
MDP manic-depressive psychosis; maximum diastolic potential; maximum digital pulse; methylene diphosphat...
MHP hemiplegic migraine; maternal health program; maternal health program; medical center health plan; 1...
PIP paralytic infantile paralysis; peak inflation pressure, peak inspiratory pressure; periodic interim ...
SIWIP self-induced water intoxication and psychosis
ACT achievement through counseling and treatment; actin; actinomycin; activated clotting time; advanced ...
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 1
DUP Duration of Untreated Psychosis
A Atropine
AT Atropine
ATR Atropine
DASE Dobutamine atropine stress echocardiography
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 9 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • atropine therapy
    ¾ÆÆ®·ÎÇÉ Ä¡·á, ¾ÆÆ®·ÎÇÉ ¿ä¹ý
  • anxiety psychosis
    ºÒ¾È Á¤½Åº´
  • childhood psychosis
    ¼Ò¾Æ±â Á¤½Åº´, ¼Ò¾Æ±â Á¤½Åº´Áõ
  • drug-induced psychosis
    ¾à¹° À¯¹ß Á¤½ÅÁõ
  • endogenous psychosis
    ³»Àμº Á¤½Åº´
    °¢Á¾ Á¤½Åº´ Áß¿¡¼­ ±× ¹ßº´ ¿øÀÎÀÌ ÁÖ·Î °³Ã¼ÀÇ ³»Àο¡ ÀÖ´Â °Í. Á¤½Å Áúº´ÀÇ ¿øÀÎÀ¸·Î´Â ³»ÀÎ À̿ܿ¡µµ ¿ÜÀÎ, ½ÉÀÎÀÌ Àִµ¥, ³»Àμº Á¤½Åº´µµ ±×·¯ÇÑ È¯°æÀÇ ¿µÇâÀ» ÀüÇô ¹ÞÁö ¾Ê´Â °ÍÀº ¾Æ´Ï´Ù. ´Ù¸¸ ±× Á¤½Åº´ ÀÇ ¹ßÇö¿¡ À־, ±× Áغñ »óÅÂ, ¿øÀÎÀ» Çü¼ºÇÏ´Â °Í Áß¿¡¼­ °¡Àå Áß¿äÇÑ ÀÇÀǸ¦ °¡Áø °ÍÀÌ ³»ÀÎ
  • manic depressive psychosis
    Á¶¿ï Á¤½ÅÁõ
  • manic psychosis
    Á¶Áõ Á¤½ÅÁõ
  • manic-depressive psychosis
    Á¶¿ïº´
    °¨Á¤ÀÇ Àå¾Ö¸¦ ÁÖ¿ä Áõ»óÀ¸·Î ÇÏ´Â ³»Àμº Á¤½Åº´. ¼øÈ¯ Á¤½Åº´, °¨Á¤ Á¤½Åº´À̶ó°íµµ ÇÑ´Ù. Á¤½Å ºÐ¿­º´°ú ÇÔ²² 2´ë ³»Àμº Á¤½Åº´À» ÀÌ·ç°í ÀÖ´Ù. »óÄèÇÑ °¨Á¤À» ÁÖÁ¶·Î ÇÏ¿© ÈïºÐ »óŸ¦ ³ªÅ¸³»´Â Á¶ »óÅÂ¿Í ºñ¾Ö, ºÒ¾ÈÀÇ °¨Á¤À» ÁÖÁ¶·Î ÇÏ¿© ¿ï »óŸ¦ ³ªÅ¸³»´Â º´»ó±â°¡ °è¼ÓÇØ¼­ ±³´ë·Î ¶Ç´Â ¿ÏÀüÈ÷ Á¤»óÀûÀÎ Á¤½Å »óŸ¦ º¸ÀÌ´Â °£Çæ±â¸¦ µÎ°í ³ªÅ¸³»´Â °ÍÀÌ Æ¯Â¡ÀÌ´Ù. ¶§·Î´Â Á¶ »óÅ ¶Ç´Â ¿ï»ó Ÿ¸ÀÌ ¹Ýº¹Çؼ­ ³ªÅ¸³ª´Â ¼öµµ ÀÖ´Ù. À̵é Á¶, ¿ïÀÇ º´»ó±â¿Í °£Çæ±âÀÇ Àå´ÜÀº ÀÏÁ¤ÇÏÁö ¾ÊÀº °ÍÀÌ Åë·ÊÀε¥, ÀϹÝÀûÀ¸·Î ¿ï »óÅ´ Á¶ »óÅ¿¡ ºñÇØ ±æ´Ù°í Çϸç, ±× Áֱ⼺À̳ª ÁÖÁ¶°¡ °¨Á¤°ú ±âºÐÀÇ º¯Á¶¿¡ ÀÖ´Ù´Â Á¡À» ÁÖ¸ñÇÏ¿© ¼øÈ¯ Á¤½Åº´ ¶Ç´Â °¨Á¤ Á¤½Åº´ µîÀ¸·Î ºÒ¸®±âµµ ÇÑ´Ù. »óÄèÇÑ ±âºÐÀ̳ª ¿ì¿ïÇÑ ±âºÐÀÇ ±¼°îÀ» ³ªÅ¸³»´Â ¼øÈ¯Àû ¼º°ÝÀ» Áö´Ñ ȯÀÚÀÇ ÁøÆøÀÇ Áõ´ë¿Í Á¶¿ïº´À» ±¸º°ÇÒ ¼ö Àִ°¡ ÇÏ´Â °ÍÀº ¸Å¿ì ¾î·Á¿î ¹®Á¦ÀÌ´Ù. ÀÌ º´À» ¾Î´Â ȯÀÚÀÇ ÀڽĿ¡°Ô¼­ ¹ßÇö ºóµµ¸¦ º¸¸é, À϶õ¼º ½Ö»ý¾Æ¿¡ÀÇ ÀÏÄ¡À²Àº, ÇаèÀÇ º¸°í¿¡ µû¸£¸é ¾à 80 %
  • senile psychosis
    ³ë³â Á¤½Åº´
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
atropine <drug> A toxic alkaloid extracted from belladonna and other members of thenightshade family, it is typically used to dilate the eye and to stopmuscular spasms.
Pharmacologic action: Parasympatholytic. Competitive blockade of acetylcholine at muscarinic receptors. Increases sinus node automaticity and AV conduction.
Uses: Treat bradycardia, asystole, and AV block
Dose: 0.5 - 1.0 mg for bradycardia every 3 - 5 min to a total dose of 0.04 mg/kg. Doses smaller than 0.5 mg can cause a paradoxical bradycardia due to sympathomimetic effects Typically 3 mg is adequate to completely block vagal effects Atropine is well absorbed via endotracheal route - administer 1-2 mg diluted in 10 mL sterile water or normal saline.
Potential complications: 1. Tachyarrhythmias 2. Exacerbation of myocardial ischemia 3. Low dose may cause paradoxical bradycardia 4. Dry mouth, urinary retention, flushed and hot skin 5. Crosses blood-brain barrier which can cause delirium
Note: The denervated heart will not respond to atropine.
(15 Mar 2000)
atropine dehydrase <enzyme> Proposed mechanism for conversion of atropine or scopolamine to apoatropine or aposcopolamine via a mechanism using hydroxysteroid sulfotransferase by guinea pig liver
Registry number: EC 2.8.2.-
Synonym: scopolamine dehydrase
(26 Jun 1999)
atropine derivatives Analogs and derivatives of atropine.
(12 Dec 1998)
atropine methonitrate The methylnitrate of atropine, with the same actions and uses as atropine, but less lipid-soluble and hence with fewer central nervous system effects; a quaternary compound.
(05 Mar 2000)
atropine methylbromide A quaternary derivative of atropine that is less lipid soluble and hence produces fewer central nervous system actions; a cycloplegic.
Synonym: atropine methylbromide.
(05 Mar 2000)
atropine sulfate An anticholinergic; a widely used soluble salt of atropine.
(05 Mar 2000)
atropine test If an injection of atropine relieves bradycardia, the condition is due to action of the vagus; if it does not, the condition may be due to an affection of the heart itself.
Synonym: atropine test.
(05 Mar 2000)
affective psychosis Psychosis with predominant affective features.
Synonym: manic psychosis.
(05 Mar 2000)
amnestic psychosis <syndrome> May occur as a sequel to chronic alcohol abuse. Features include personality changes, confabulation, psychosis, disorientation, polyneuritis, insomnia and hallucinations.
(27 Sep 1997)
arteriosclerotic psychosis Psychotic disturbance in elderly persons suffering from cerebral arteriosclerosis.
(05 Mar 2000)
bipolar psychosis A mental disorder characterised by one or more episodes of mania (manic depression) which is usually accompanied by one or more episodes of depression (major depressive episode).
See: endogenous depression, manic-depressive.
(05 Mar 2000)
brief reactive psychosis <psychiatry> A brief display of psychotic behaviour that lasts for at least several hours, but not more than one week. Typically these reactions are brought on by periods of increased stress (for example death of a loved one).
Symptoms include delusions, hallucinations, disordered thinking, impaired speech and bizarre dress.
(27 Sep 1997)
manic-depressive psychosis Perviously referred to as manic depressive illness, characterised by the occurrence of mania (euphoria) alternating with bouts of depression.
(27 Sep 1997)
manic psychosis Psychosis with predominant affective features.
Synonym: manic psychosis.
(05 Mar 2000)
gestational psychosis An obsolete term for psychotic reaction with morbid depressive features associated with pregnancy.
See: postpartum psychosis, puerperal psychosis.
(05 Mar 2000)
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 4 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • atropine
    ¾ÆÆ®·ÎÇÉ
  • psychosis
    Á¤½Åº´
  • atropine
    ¾ÆÆ®·¯ÇÉ(Áø°æÁ¦·Î ¾²ÀÌ´Â µ¶¾à)
  • psychosis
    Á¤½Åº´;Á¤½Å ÀÌ»ó 
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 1
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 1
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 1
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 1
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 1
ÅëÇÕ°Ë»ö ¿Ï·á